Xencor, Inc.
A biopharmaceutical company developing monoclonal antibodies and other protein drugs. The company is developing drugs using its XmAb technology, designed to treat cancer, autoimmune and allergic diseases. The company is based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 280 |
Founded | 1997 |
Financials | |
|---|---|
Market Capitalization | 1.22B |
Revenue | 162.18M |
Operating Income | -137.13M |
Operating Margin | -84.55% |
Net Income | -133.36M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4939 / 5373 |
Sector : Healthcare | 958 / 1144 |
Industry : Biotechnology | 506 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 2318 / 5565 |
Sector : Healthcare | 297 / 1182 |
Industry : Biotechnology | 114 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4920 / 5436 |
Sector : Healthcare | 966 / 1164 |
Industry : Biotechnology | 521 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3337 / 5330 |
Sector : Healthcare | 397 / 1174 |
Industry : Biotechnology | 100 / 667 |